Table 3.
AMG 181 assay type | Species | Cell type | Parameter or result |
---|---|---|---|
Receptor binding affinity | Human | HuT78 cells expressing α4β7 | Kd = 0.9 (0.2–2.3)a pM |
Receptor binding specificity | Human | HEK 293 T cellsb | Specific binding to α4β7 |
Binding to primary T cells | Human | CD4+CD45RA-memory T cells | EC50 = 4.0 ng·mL−1 (26 pM) |
Cynomolgus monkey | CD4+CD28+CD95+ CM T cells | EC50 = 2.6 ng·mL−1 (17 pM) | |
Blocking of α4β7:MAdCAM-1 binding | Human | CD4+CD45RA-memory T cells | IC50 = 6.4 ng·mL−1 (42 pM) |
Cynomolgus monkey | CD4+CD28+CD95+ CM T cells | IC50 = 4.5 ng·mL−1 (30 pM) | |
Blocking of T cell adhesionc | Human | HuT78 cells | IC50 = 1.5 ng·mL−1 (10 pM) |
Human | Purified T cells | IC50 = 12.0 ng·mL−1 (80 pM) | |
Cynomolgus monkey | Purified T cells | IC50 = 12.6 ng·mL−1 (84 pM) |
Optimal Kd (95% confidence interval range).
Transiently co-transfected with expression vectors for α4β7, α4β1 or αEβ7 subunits.
α4β7 : MAdCAM-1-mediated T cell adhesion.